IMAGING OXYGEN METABOLISM IN BRAIN
大脑中氧代谢成像
基本信息
- 批准号:6056640
- 负责人:
- 金额:$ 3.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Ischemic stroke is a
common and devastating disorder. The long-term goal of this project is to
develop a tool to study the pathophysiology of stroke and in particular the
ischemic penumbra. In the ischemic core blood flow is <20 percent of normal
and metabolism is almost absent. The peripheral regions also have reduced
blood flow (20 to 50 percent of normal) but are only slightly hypometabolic.
This region is called the "ischemic penumbra". It has been shown that this
region can be salvaged with early treatment. These areas are also involved
in active protein synthesis which is thought to endow ischemic tolerance.
The applicant hypothesizes that in vivo magnetic resonance imaging (MRI) of
oxygen consumption can distinguish penumbral regions from infarcted regions
in the setting of focal ischemia. In order to test this hypothesis the
applicant proposes to develop novel MR methods to image cerebral oxygen
metabolism and blood flow. The methods are based on indirect detection of
the 17-0 nucleus using 1H MRI, which has already been demonstrated to be a
sensitive technique. The applicant will evaluate this method in normal rats
and validate it against existing methods for measuring cerebral oxygen
metabolism. He will then use this method to study a reversible model of
stroke involving occlusion of middle cerebral artery. The phenomenon of
ischemic tolerance will be investigated by correlating MR data with
immunohistochemical assays for protein expression. In this way, he hopes to
be able to correlate MR images with protein synthesis. This project will
greatly enhance our understanding of the pathophysiology of stroke and
possibly provide a tool with which to noninvasively assess genetic
therapies.
描述(改编自申请人摘要):缺血性中风是一种疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UMAMAHESWAR DUVVURI其他文献
UMAMAHESWAR DUVVURI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UMAMAHESWAR DUVVURI', 18)}}的其他基金
Novel Targets to Treat Head & Neck Cancer in Veterans
治疗头部的新目标
- 批准号:
10512034 - 财政年份:2021
- 资助金额:
$ 3.69万 - 项目类别:
Inhibition of lysosomal flux in carcinogen-induced head and neck cancer
抑制致癌物诱发的头颈癌中的溶酶体通量
- 批准号:
10306375 - 财政年份:2019
- 资助金额:
$ 3.69万 - 项目类别:
Inhibition of lysosomal flux in carcinogen-induced head and neck cancer
抑制致癌物诱发的头颈癌中的溶酶体通量
- 批准号:
10542340 - 财政年份:2019
- 资助金额:
$ 3.69万 - 项目类别:
Inhibition of lysosomal flux in carcinogen-induced head and neck cancer
抑制致癌物诱发的头颈癌中的溶酶体通量
- 批准号:
10993897 - 财政年份:2019
- 资助金额:
$ 3.69万 - 项目类别:
Novel targets to treat head and neck cancer in Veterans
治疗退伍军人头颈癌的新靶点
- 批准号:
9138391 - 财政年份:2016
- 资助金额:
$ 3.69万 - 项目类别:
QUANTIFICATION OF GENE EXPRESSION W/ LABELED ANTIBODIES: GENE THER, HIV VACCINE
使用标记抗体对基因表达进行定量:基因、HIV 疫苗
- 批准号:
6252184 - 财政年份:1997
- 资助金额:
$ 3.69万 - 项目类别:














{{item.name}}会员




